Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same
    6.
    发明授权
    Vitro engineered, regenerated urinary tract tissue compositions and methods for producing same 失效
    体外工程化,再生尿道组织组合物及其制备方法

    公开(公告)号:US07122200B2

    公开(公告)日:2006-10-17

    申请号:US10013270

    申请日:2001-12-10

    IPC分类号: A61F13/00 A01N65/00 C12N5/08

    摘要: A method for providing a urinary tract tissue graft composition includes providing a tissue culture frame and a segment of small intestinal submucosa and positioning the segment of small intestinal submucosa in the tissue culture frame such that the segment of small intestinal submucosa is suspended and held in a taut position by the tissue culture frame. Smooth muscle and urothelial cells are isolated from a tissue specimen of a subject and cultured, and then seeded upon the segment of small intestinal submucosa, thereby forming a urinary tract tissue graft. A tissue culture frame in which such a urinary tract tissue graft may be formed is also disclosed.

    摘要翻译: 提供尿道组织移植组合物的方法包括提供组织培养框架和小肠粘膜下层的一部分,并将小肠粘膜下层的部分定位在组织培养框架中,使得小肠粘膜下层的部分被悬浮并保持在 由组织培养框架拉紧位置。 从受试者的组织标本中分离平滑肌和尿路上皮细胞并培养,然后接种在小肠粘膜下层的段上,从而形成尿道组织移植物。 还公开了可以形成这种尿道组织移植物的组织培养框架。

    Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells
    10.
    发明申请
    Method for Treating Diabetes and Other Glucose Regulation Disorders Using Stem Cells 有权
    使用干细胞治疗糖尿病和其他葡萄糖调节障碍的方法

    公开(公告)号:US20160040131A1

    公开(公告)日:2016-02-11

    申请号:US14833403

    申请日:2015-08-24

    申请人: Incube Labs LLC

    发明人: Mir Imran

    IPC分类号: C12N5/071 A61K35/38

    摘要: Various embodiments of the invention provide methods of treating diabetes and other glucose regulation disorders. In one embodiment, the method comprises removing L-cells from a donor, obtaining stem cells from a patient, and culturing the L-cells in the presence of the stem cells under conditions such that the stem cells differentiate into stem cell-derived L-cells (SCDLC). An amount of the SCDLC is introduced into the patient sufficient to cause a lowering of the patient's blood glucose level after ingestion of food. In another embodiment, the method comprises removing K-cells from a donor, obtaining stem cells from a patient, and culturing the K-cells in the presence of the stem cells under conditions such that the stem cells differentiate into stem cell-derived K-cells (SCDKC). An amount of the SCDKC is introduced into the patient sufficient to cause a lowering of the patient's blood glucose level after ingestion of food.

    摘要翻译: 本发明的各种实施方案提供了治疗糖尿病和其它葡萄糖调节障碍的方法。 在一个实施方案中,该方法包括从供体中除去L-细胞,从患者获得干细胞,并在干细胞存在下培养L细胞,使得干细胞分化成干细胞衍生的L-细胞, 细胞(SCDLC)。 将足够的SCDLC量引入到患者摄取食物后降低患者的血糖水平。 在另一个实施方案中,该方法包括从供体中除去K细胞,从患者获得干细胞,并在干细胞存在下培养K细胞,使得干细胞分化成干细胞衍生的K- 细胞(SCDKC)。 将足够的SCDKC的量引入到患者摄取食物后使患者的血糖水平降低。